You are here: 

Research in diagnosis and prognosis

A key area of research looks at better ways to diagnose and stage cancer, as well as predict prognosis. A prognosis is the doctor’s best estimate of how cancer will affect someone and how the cancer will respond to treatment. Both doctors and people with cancer depend on information gathered from tests used to diagnose and predict prognosis to help make treatment and care decisions.

Researchers are studying some tests and tools to help diagnose, stage and predict prognosis for different types of cancer.

Tumour marker tests

Biomarkers are normal materials of the body that can be measured within cells, tissue or fluids. Genes, chromosomes and proteins are all biomarkers. Researchers are studying different biomarkers to try to find which ones are helpful at finding cancer or predicting prognosis and response to treatment. Some biomarkers are found in abnormal amounts in people with cancer. For example, a protein may be found in higher than normal amounts or a chromosome that should be there is missing. When biomarkers are used to find or understand more about cancer, they are also called tumour markers.

Some tumour markers are specific to one type of cancer, while others are related to more than one type of cancer. More than 20 tumour markers are currently used to make cancer treatment decisions. But some types of cancer don’t have any known tumour markers yet. To help understand more about cancer types, researchers are collecting and storing tissue samples from cancerous tumours. This is called tumour banking or biobanking. It allows researchers to later study tumours to look at genes, proteins and other features that could potentially be used as tumour markers.

Developing new tumour marker tests can help doctors to find cancer earlier, improve diagnosis and predict prognosis. Tumour marker tests allow doctors to better understand cancer, such as whether it is more or less likely to spread or how it will respond to treatment. Tumour marker tests help doctors choose treatment by identifying targets for targeted therapy drugs. Tumour markers and tumour marker tests are part of the growing field of personalized medicine.

Gene-based diagnostic tests

Gene-based tests find differences between normal genes and genes that are changed (mutated) in cancer cells. Genes are pieces of DNA that tell each cell in your body what to do. Doctors sometimes look at DNA, an entire gene or many genes together to see if there are changes. Doctors can use genes that are changed or mutated as tumour markers. Researchers have linked some genetic changes or mutations to cancer, but we are only beginning to uncover the full picture of which genes may or may not be involved. For example, mutations in the BRCA1 and BRCA2 gene are linked to breast cancer and mutations in the EGFR gene are linked to some non–small cell lung cancers.

Microarray analysis is a type of gene-based test that allows researchers to look at many genes together. This test can find genes that are turned on or off because of gene mutations or other genetic changes that may be related to a certain type of cancer. Analyzing many genes at the same time to see which are turned on and which are turned off is called gene expression profiling.

Eventually, researchers hope that more and more gene-based diagnostic tests will help doctors identify the best treatments for specific cancers and that more treatments will be tailored to each person’s cancer.

Liquid biopsy

A liquid biopsy tests the blood or other body fluid for cancer. It looks for pieces of tumour DNA (called circulating tumour DNA) in the blood and can be done on a sample of blood removed during a blood test. In a standard biopsy, a doctor removes tissue from the body with a procedure that usually involves surgery or a needle. Doctors then recommend treatments based on what this sample of tissue tells them about the cancer.

A liquid biopsy is an exciting alternative to a standard biopsy. Researchers want to find out if using a liquid biopsy can find cancer as well as a standard biopsy does. Even if it can, a standard biopsy will probably be used for most people because it gives doctors a lot of useful information about the cancer.

But having a liquid biopsy may be a good option for someone who isn’t well enough to have a standard biopsy. A liquid biopsy may also be used if there isn’t enough tissue to remove and test or if the tumour is in a place that makes a standard biopsy hard to do. A possible advantage of liquid biopsy may even be that it could provide information about the tumour that a standard biopsy can’t. During a standard biopsy, only a small piece of the tumour is removed and tested. Tumour DNA that is circulating in the blood may contain different information that isn’t seen on the tissue sample.

A liquid biopsy may be most useful in looking for cancer that has come back as part of follow-up care after treatment has ended. Since tumour DNA may not be found in the blood right after treatment, it’s best to test for tumour DNA a while (such as a few months) after treatment is done.   

Robotic biopsy

A robotic biopsy removes cells or tissue to look at under a microscope. A robotic biopsy uses robotic surgery, which is often done by laparoscopy through 5 to 6 small surgical cuts (incisions). In robotic surgery, the doctor sits at a computer station close to the operating table, watches a monitor with live video and uses controls to move 2 or 3 robotic arms that are connected to surgical instruments that remove tissue.

Imaging techniques and devices

Imaging tests, such as x-ray, MRI, ultrasound and CT scans, are a common way to rule out or confirm many diseases, including cancer. Imaging uses special machines and techniques to create images of the inside the body to see how well it is working. Imaging is a way for doctors to find the exact location of cancer and to check for cancer that has spread. Information from imaging tests is used to stage cancer and help plan treatment.

Researchers are developing new imaging tests and continue to study current imaging tests to see if they can find better ways to diagnose cancer, predict prognosis and plan treatment.

Virtual endoscopy

Virtual endoscopy is an imaging test that uses a CT scan to create images of the inside of an organ. A computer makes a 3-D picture of the organ from several images. Doctors can use this 3-D view to look at the lining of an organ much like they would during a regular endoscopic procedure, but without having to insert an endoscope. Researchers are looking at virtual endoscopy as a way to diagnose and stage colorectal and lung cancers.

Breast tomosynthesis

Breast tomosynthesis is an imaging test similar to mammography. It uses an x-ray machine that moves around the breast and takes pictures. The pictures can be stacked together to make a 3-D image of the breast to help doctors find breast cancer. Researchers are trying to find out if breast tomosynthesis can detect breast cancer better than mammography.

Improving nuclear medicine and other imaging techniques that are currently used

Researchers are looking at ways to make current imaging tests better. For example, they are trying to make spiral (multi-slice) CT scanners work faster and improve the quality of the images to give more detail.

Nuclear medicine imaging tests look at changes to molecules inside of the body to help diagnose cancer. It is a type of medical imaging that uses radiopharmaceuticals to look at organs and tissues and see how well they are working. Some nuclear medicine imaging tests that researchers are trying to improve include positron emission tomography (PET) scan and single photon emission computed tomography (SPECT). Both use radiopharmaceuticals and a scanning machine to collect information about molecules in the body. A computer uses this information to create images. SPECT gives information about blood flow and how the body’s cells are working.

Lower radiation doses

Many imaging tests, such as CT scans and x-ray, use radiation. Imaging machines that use high doses of radiation, such as CT and nuclear medicine imaging tests, are being used more often than they were in the past. So researchers are trying to develop better guidelines to protect people from medical radiation, such as:

  • using these tests only when they are absolutely needed
  • using other tests that don’t give off radiation (such as ultrasound) when possible
  • making sure the radiation machines deliver radiation properly so you don’t get a higher dose than what you need to treat the cancer
  • tailoring radiation doses to each person based on their size so that as little radiation as possible is used (this is especially important for children)
  • keeping track of how much medical radiation you are exposed to
  • monitoring better how much radiation the machines deliver

Researchers think this will help to make sure you have the benefit of tests that use medical radiation when you need them but with as little risk as possible.

gene

The basic biological unit of heredity passed from parents to a child. Genes are pieces of DNA and determine a particular characteristic of an individual.

deoxyribonucleic acid (DNA)

The molecules inside the cell that program genetic information. DNA determines the structure, function and behaviour of a cell.

endoscopy

A procedure that uses an endoscope (a thin, tube-like instrument with a light and lens) to examine or treat organs or structures in the body.

Cells or tissue may be removed for examination under a microscope. Doctors may also use endoscopy to control bleeding or remove tumours and foreign bodies.

Specialized endoscopies are named for the organ or structure they examine or treat.

mammography

A procedure used to x-ray the breast.

Doctors use mammography to look for tumours or cysts (sacs that are usually filled with fluid or semi-solid material) in the breasts.

Different types of mammography include screening mammography and diagnostic mammography.

The x-ray image produced is called a mammogram.

radiopharmaceutical

A drug that contains a radioactive substance.

A radiopharmaceutical can be used to diagnose and treat cancer and other diseases.

Also called radioactive drug.

Stories

Dr Simon Graham Developed a new technology for brain cancer surgery

Read more

What’s the lifetime risk of getting cancer?

Icon - 1 in 2

The latest Canadian Cancer Statistics report shows about half of Canadians are expected to be diagnosed with cancer in their lifetime.

Learn more